Skip to content

Role of Individualized Homoeopathic medicine in treatment of seborrheic dermatitis and its impact on quality of life a single arm pre post clinical study

Role of Individualized Homoeopathic medicine in treatment of seborrheic dermatitis and its impact on quality of life a single arm pre post clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067321
Enrollment
40
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L219- Seborrheic dermatitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine in 50 millesimal or centesimal potency: Medicine will be prescribed in Centesimal or Fifty Millesimal potency, according to Homoeopathic principles

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) Clinically diagnosed cases of SD (ICD-10 code- L29.1) (b) Aged between 20 – 60 years and all genders. (c) Patients not receiving any topical treatment for SD on last 3 months. (d) Patients who can read and/or understand either Hindi or English or Bengali. (e) Patients who are willing to give consent

Exclusion criteria

Exclusion criteria: (a) Pregnant and lactating women. (b) Associated systemic or immune compromised illness. (c) Patients under other medications for any chronic disease. (d) Diagnosed cases of any life threatening, malignant or psychiatric diseases. (e) Simultaneous participation in any other clinical trials (f) Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
SDASI; SDASI is a scoring system used for assessment of SD. Parts of the body affected with SD are examined in the patients and grading for erythema, papule and scale. Assessment of the degree of erythema (E), papules (P). and scales (S) on each area • Determination of the local area score on each area, which is the percentage of SD symptom on the affected area are compared to the surrounding area • Calculation of SDASI score of each area is done with the equation (E+P+S) × Local Area Score • Quantification of all three SDASI scores • Classification of SD severity according to the SDASI score Timepoint: At baseline and after 6 months

Secondary

MeasureTime frame
SKINDEX 29Timepoint: At baseline and after 6months

Countries

India

Contacts

Public ContactDr SANKARDAS CHAKRABARTI

NATIONAL INSTITUTE OF HOMOEOPATHY

drchakrabartisir.madam@gmail.com9421494947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026